Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report Open Access

Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report

  • Authors:
    • Yan Chen
    • Li Zhang
    • Jiankun Huang
    • Xiuli Hong
    • Jiangning Zhao
    • Zhao Wang
    • Kejie Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Hematology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, P.R. China, Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Central Laboratory, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, P.R. China
    Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3979-3984
    |
    Published online on: August 28, 2017
       https://doi.org/10.3892/etm.2017.5046
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to evaluate the therapeutic efficacy of dasatinib in a patient with nucleoporin 214‑tyrosine protein kinase ABL1 proto‑oncogene 1 (NUP214‑ABL1)‑positive early T‑cell precursor‑acute lymphoblastic leukemia (ETP‑ALL), as well as that of selinexor and dasatinib for NUP214‑ABL1‑positive ETP‑ALL in vitro. ETP leukemia is a form of T‑cell ALL (T‑ALL) with poor prognosis. The NUP214‑ABL1 gene is present in ~6% of T‑ALL cases, however the prevalence of NUP214‑ABL1 gene expression in ETP‑ALL in particular has not yet been verified. The current study reports the rare case of a 29‑year‑old man with ETP‑ALL harboring the NUP214‑ABL1 fusion gene, presenting with low‑grade fever, stomachache and splenomegaly. The patient was successfully treated with dasatinib and vincristine, idarubicin, cyclophosphamide and prednisone (VICP) chemotherapy. The therapeutic efficacy of selinexor and dasatinib was also evaluated in vitro. Apoptosis was analyzed using Annexin V/propidium iodide staining and flow cytometry, and poly ADP‑ribose polymerase (PARP) cleavage was detected using western blot analysis. The results demonstrated that the apoptotic cell population significantly increased following selinexor or dasatinib treatment compared with the control (P<0.05). Furthermore, combined selinexor and dasatinib treatment led to a significant increase in cell apoptosis compared with either treatment alone (P<0.05). The apoptosis results were confirmed by PARP cleavage. Thus, NUP214‑ABL1 fusion gene expression should be tested in T‑ALL, including ETP‑ALL. Dasatinib used in combination with traditional induction chemotherapy may reverse the high induction failure of ETP‑ALL with NUP214‑ABL1 fusion gene; however, further prospective studies are required to confirm this. Therefore, selinexor with or without dasatinib may serve as a potential salvage therapy in the case of relapse and may be developed as a novel treatment for ETP‑ALL with the NUP214‑ABL1 fusion gene.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Jain N, Lamb AV, O'Brien S, Ravandi F, Konopleva M, Jabbour E, Zuo Z, Jorgensen J, Lin P, Pierce S, et al: Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: A high-risk subtype. Blood. 127:1863–1869. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, Cheng C, Su X, Rubnitz JE, Basso G, et al: Early T-cell precursor leukaemia: A subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 10:147–156. 2009. View Article : Google Scholar : PubMed/NCBI

3 

De Keersmaecker K, Marynen P and Cools J: Genetic insights in the pathogenesis of T cell acute lymphoblastic leukemia. Haematologica. 90:1116–1127. 2005.PubMed/NCBI

4 

Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, Vermeesch JR, Stul M, Dutta B, Boeckx N, et al: Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet. 36:1084–1089. 2004. View Article : Google Scholar : PubMed/NCBI

5 

Pante N, Bastos R, McMorrow I, Burke B and Aebi U: Interactions and three-dimensional localization of a group of nuclear pore complex proteins. J Cell Biol. 126:603–617. 1994. View Article : Google Scholar : PubMed/NCBI

6 

De Keersmaecker K, Porcu M, Cox L, Girardi T, Vandepoel R, de Beeck JO, Gielen O, Mentens N, Bennett KL and Hantschel O: NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins. Haematologica. 99:85–93. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Hutten S and Kehlenbach RH: Nup214 is required for CRM1-dependent nuclear protein export in vivo. Mol Cell Biol. 26:6772–6785. 2006. View Article : Google Scholar : PubMed/NCBI

8 

De Keersmaecker K, Rocnik JL, Bernad R, Lee BH, Leeman D, Gielen O, Verachtert H, Folens C, Munck S, Marynen P, et al: Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore. Mol Cell. 31:134–142. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, et al: The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 481:157–163. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Leinonen EA: Cytochemical studies of acute leukemias. Acta Haematol. 43:219–227. 1970. View Article : Google Scholar : PubMed/NCBI

11 

Tamul KR, Meyers DC, Bentley SA and Folds JD: Two color flow cytometric analysis of concomitant acute myeloid leukemia and chronic lymphocytic leukemia. Cytometry. 18:30–34. 1994. View Article : Google Scholar : PubMed/NCBI

12 

Summer AT, Evans HJ and Buckland RA: New technique for distinguishing human chromosomes. Nature. 232:31–32. 1971.

13 

Pallisgaard N, Hokland P, Riishøj DC, Pedersen B and Jørgensen P: Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood. 92:574–588. 2014.

14 

Etchin J, Sanda T, Mansour MR, Kentsis A, Montero J, Le BT, Christie AL, McCauley D, Rodig SJ, Kauffman M, et al: KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Br J Haematol. 161:117–127. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Quintás-Cardama A, Tong W, Manshouri T, Vega F, Lennon PA, Cools J, Gilliland DG, Lee F, Cortes J, Kantarjian H, et al: Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies. Leukemia. 22:1117–1124. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Zhang YL, Guang MH, Zhuo HQ, Min XH, Yao Q, Gu AQ, Wu SH, Zhang DB, Lu JY, Chen Y, et al: Carfilzomib inhibits constitutive NF-κB activation in mantle cell lymphoma B cells and leads to the induction of apoptosis. Acta Haematol. 137:106–112. 2017. View Article : Google Scholar : PubMed/NCBI

17 

De Keersmaecker K, Marynen P and Cools J: Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica. 90:1116–1127. 2005.PubMed/NCBI

18 

Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C and Bloomfield CD: Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762). Blood. 80:2983–2990. 1992.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen Y, Zhang L, Huang J, Hong X, Zhao J, Wang Z and Zhang K: Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report. Exp Ther Med 14: 3979-3984, 2017.
APA
Chen, Y., Zhang, L., Huang, J., Hong, X., Zhao, J., Wang, Z., & Zhang, K. (2017). Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report. Experimental and Therapeutic Medicine, 14, 3979-3984. https://doi.org/10.3892/etm.2017.5046
MLA
Chen, Y., Zhang, L., Huang, J., Hong, X., Zhao, J., Wang, Z., Zhang, K."Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report". Experimental and Therapeutic Medicine 14.5 (2017): 3979-3984.
Chicago
Chen, Y., Zhang, L., Huang, J., Hong, X., Zhao, J., Wang, Z., Zhang, K."Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report". Experimental and Therapeutic Medicine 14, no. 5 (2017): 3979-3984. https://doi.org/10.3892/etm.2017.5046
Copy and paste a formatted citation
x
Spandidos Publications style
Chen Y, Zhang L, Huang J, Hong X, Zhao J, Wang Z and Zhang K: Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report. Exp Ther Med 14: 3979-3984, 2017.
APA
Chen, Y., Zhang, L., Huang, J., Hong, X., Zhao, J., Wang, Z., & Zhang, K. (2017). Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report. Experimental and Therapeutic Medicine, 14, 3979-3984. https://doi.org/10.3892/etm.2017.5046
MLA
Chen, Y., Zhang, L., Huang, J., Hong, X., Zhao, J., Wang, Z., Zhang, K."Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report". Experimental and Therapeutic Medicine 14.5 (2017): 3979-3984.
Chicago
Chen, Y., Zhang, L., Huang, J., Hong, X., Zhao, J., Wang, Z., Zhang, K."Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report". Experimental and Therapeutic Medicine 14, no. 5 (2017): 3979-3984. https://doi.org/10.3892/etm.2017.5046
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team